Biotech Startups

Taysha Gene Therapies develops and commercializes gene therapies for monogenic diseases of the central nervous system, serving patients with rare and larger CNS conditions. Its lead clinical program targets Rett syndrome, alongside a broader pipeline of CNS programs.

1 investor

TAZ develops anti-aging products and drug discovery research focused on cellular senescence removal and longevity science. The company provides biomarker testing services, contract product development, and drug candidates to extend healthspan in an aging society.

1 investor

The Biological Computing Co. uses living neurons to study how biological systems process information and applies those insights to improve AI model training and inference. It aims to build a new class of computing hardware that learns and adapts with lower time, energy, and training costs than silicon.

1 investor

1 investor

Designs and manufactures medical imaging and particle therapy equipment for cancer treatment and diagnostic visualization. Products include ultrasound systems for brachytherapy procedures, cyclotrons for radiopharmaceutical production, and synchrotrons for particle therapy.

1 investor

Tech4Meat develops cultivated meat using cellular agriculture, creating protein foods without intensive animal farming. The company targets consumers seeking sustainable, ethical meat alternatives with minimal environmental impact.

1 investor

Technical Safety Services provides regulatory compliance, testing, certification, calibration, and maintenance services for laboratory equipment and controlled environments used by life sciences and healthcare organizations. The company offers professional services including commissioning, qualification, validation, and decommissioning across research, manufacturing, and patient care facilities.

1 investor

TEKMOF develops Metal Organic Frameworks (MOFs) using kinetic-controlled design for molecular trapping, adsorption, and molecular structure determination. It offers porous materials, molecular structure analysis consulting, and analysis equipment and software for the pharmaceutical, food, environmental, and energy sectors.

1 investor

Teknova develops reagents and custom buffer solutions for AAV (adeno-associated virus) downstream processing in gene therapy workflows. The company leverages 30 years of manufacturing expertise to address bottlenecks in AAV production for researchers and biotech organizations.

1 investor

Tekton Research is a multi-specialty clinical research site organization founded in 2006 that conducts Phase 1-4 trials by partnering with pharmaceutical sponsors and contract research organizations. The company operates both embedded physician practices and standalone research centers led by clinical experts in cardiometabolic care, obesity, neurology, and psychiatry.

1 investor

Telepathic (Telepath Technologies) develops non-invasive brain-computer interfaces that read, interpret, and transmit neural signals in real time without surgery or implants. It combines hardware, software, and AI to enable communication and interaction between humans and machines.

1 investor

Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices. The page does not describe the company's products or business activities.

1 investor

Telica Microbials develops biological insecticides derived from a bitter natural substance to control thrips and mites at low doses, using a proprietary formulation. Its botanical plant-protection products are aimed at agricultural pest control without harmful effects on bees.

1 investor

Tellgen is a Chinese in vitro diagnostics company that develops, manufactures, and sells diagnostic products and reagents for clinical laboratories. The company specializes in tumor markers, HPV detection, genetic mutation testing, autoimmune disease markers, and biochemical reagents using technologies including flow cytometry, chemiluminescence, and mass spectrometry.

1 investor

Telomere Therapeutics is a gene therapy company developing treatments that repair telomeres to address organ fibrosis and telomere-dysfunction syndromes. Its lead program is an AAV-based therapy for idiopathic pulmonary fibrosis (IPF).

1 investor

Tempo Therapeutics is a biotechnology company developing therapeutics, with a focus that includes dermatology. Its team works on a pipeline built around its underlying technology platform.

1 investor

Temprian Oncology develops nanoparticle-based "Supercarriers" that deliver a prodrug toxic to melanoma cells, releasing the active ingredient inside metastatic melanoma tumor cells in low-pH pigment-making organelles. The therapy targets late-stage, metastasized melanoma and is designed to work alongside or replace existing TKI and immune checkpoint inhibitor treatments.

1 investor

Temprian Therapeutics is a biopharmaceutical company developing an HSP70i-based immunotherapy for vitiligo. It focuses on advancing a treatment for pigmentation disorders through clinical development.

1 investor

Ten Lives makes sustainable cat snacks and food using fermentation to brew animal-free protein (microbes converting sugar to protein) that matches what cats eat in the wild. The products are vegan but formulated for carnivore health, aiming to reduce meat consumed by pets and the associated environmental impact.

1 investor

IBSRELA is a prescription medication containing tenapanor designed to treat irritable bowel syndrome with constipation (IBS-C) in adults by reducing constipation and abdominal pain. The drug works by increasing intestinal water retention, supporting gut lining integrity, and reducing pain-sensing nerve sensitivity.

1 investor

Tenax Therapeutics is a clinical-stage pharmaceutical company developing TNX-103, an oral formulation of the drug levosimendan, to treat pulmonary hypertension resulting from heart failure with preserved ejection fraction (PH-HFpEF). The company focuses on this cardiovascular and pulmonary disease, which currently has no approved treatments.

1 investor

Tenboron develops boron carriers for boron neutron capture therapy (BNCT), a form of targeted radiation treatment for cancer. The company creates regulatory-approved pharmaceutical compounds to be used with accelerator-based neutron sources in clinical oncology.

1 investor

Tend develops therapeutic solutions and diagnostic tools focused on the gut microbiome to treat chronic intestinal and digestive health conditions. The company serves researchers, clinicians, and patients seeking evidence-based alternatives to traditional disease management approaches.

1 investor

TendoNova develops microinvasive medical technology, including its Ocelot Nano device, to treat chronic tendon pain in patients. The company targets clinical use for patients with tendon injuries, including athletes.

1 investor